Related Experiment Video
Updated: Oct 4, 2025
05:35
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
959
Anemia in cirrhosis: An underestimated entity
Manish Manrai1, Saurabh Dawra2, Rajan Kapoor3
1Department of Internal Medicine, Armed Forces Medical College, Pune 411040, India. manishmanrai@yahoo.com.
World Journal of Clinical Cases
|February 7, 2022
Summary
Anemia is a common complication in cirrhosis patients, often overlooked. This study analyzes its causes and proposes diagnostic and management strategies for better patient care.
Area of Science:
- Hepatology
- Gastroenterology
- Hematology
Background:
- Anemia is a frequent and significant clinical issue in patients with cirrhosis.
- Management dilemmas arise regarding its cause and optimal treatment strategies.
- Anemia prevalence and severity correlate with liver disease progression.
Purpose of the Study:
- To critically analyze the pathophysiological mechanisms of anemia in cirrhosis.
- To emphasize a diagnostic flowchart for anemia in cirrhotic patients.
- To propose management protocols for anemia in cirrhosis.
Main Methods:
- Literature review and critical analysis of existing data.
- Examination of diagnostic approaches for multifactorial anemia.
- Evaluation of current and proposed management strategies.
Main Results:
- Anemia in cirrhosis can stem from various factors including blood loss, nutritional deficiencies, and viral hepatitis.
- A systematic diagnostic approach is crucial for identifying the underlying causes.
- Management requires addressing multifactorial etiologies and disease severity.
Conclusions:
- Anemia in cirrhosis is complex and requires a tailored diagnostic and management plan.
- Early recognition and intervention can improve patient outcomes.
- Further research into optimal management protocols is warranted.
Related Concept Videos
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
6
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
6
01:28Esophageal Varices-II: Clinical Features and Management
168
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
168
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
10
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
10
01:27Disorders of Erythrocytes
1.3K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.3K
01:26Diseases of the Liver and Gallbladder
1.1K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.1K
01:24Esophageal Varices-I: Introduction
421
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
421